| Literature DB >> 33431425 |
Donya Mohebali1, Michelle M Kittleson2.
Abstract
The incidence of heart failure (HF) remains high and patients with HF are at risk for frequent hospitalisations. Remote monitoring technologies may provide early indications of HF decompensation and potentially allow for optimisation of therapy to prevent HF hospitalisations. The need for reliable remote monitoring technology has never been greater as the COVID-19 pandemic has led to the rapid expansion of a new mode of healthcare delivery: the virtual visit. With the convergence of remote monitoring technologies and reliable method of remote healthcare delivery, an understanding of the role of both in the management of patients with HF is critical. In this review, we outline the evidence on current remote monitoring technologies in patients with HF and highlight how these advances may benefit patients in the context of the current pandemic. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: cardiomyopathy; dilated; heart failure; systolic; telemedicine
Year: 2021 PMID: 33431425 DOI: 10.1136/heartjnl-2020-318062
Source DB: PubMed Journal: Heart ISSN: 1355-6037 Impact factor: 5.994